Shi Wei
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 32
- MicroRNA in disease regulation 5
- Rheumatology 24
- Bone Tumor Diagnosis and Treatments 19
- Soft tissue tumor case studies 5
- Co-authors
- Gene P. Siegal (60 shared papers)Omar Hameed (13 shared papers)Zhiyong Ren (3 shared papers)Tiansheng Shen (7 shared papers)Abha Soni (2 shared papers)Margaret S. Brandwein‐Gensler (4 shared papers)Charity Johanna Morgan (2 shared papers)Jie Xu (1 shared paper)
- Journals
- Human Pathology (11 papers)Modern Pathology (7 papers)Clinical Breast Cancer (6 papers)Breast Cancer Research and Treatment (5 papers)American Journal of Clinical Pathology (5 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Shi Wei
126 papers receiving 3.5k citations
Shi Wei's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 1.1k
- Oncology 711
- Pulmonary and Respiratory Medicine 570
- Pathology and Forensic Medicine 204
- Rheumatology 124
Countries citing papers authored by Shi Wei
This map shows the geographic impact of Shi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Wei more than expected).
Fields of papers citing papers by Shi Wei
This network shows the impact of papers produced by Shi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Wei. The network helps show where Shi Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue Hit paper breakdown → | 2022 | 279 |
| 2 | 2014 | 243 | |
| 3 | 2015 | 215 | |
| 4 | 2020 | 176 | |
| 5 | 2016 | 149 | |
| 6 | 2017 | 113 | |
| 7 | 2020 | 110 | |
| 8 | 2015 | 101 | |
| 9 | 2021 | 85 | |
| 10 | 2017 | 69 | |
| 11 | 2014 | 62 | |
| 12 | 2006 | 61 | |
| 13 | 2016 | 59 | |
| 14 | 2022 | 54 | |
| 15 | 2007 | 52 | |
| 16 | 2017 | 49 | |
| 17 | 2015 | 47 | |
| 18 | 2014 | 46 | |
| 19 | 2020 | 46 | |
| 20 | 2016 | 44 |
About Shi Wei
Shi Wei is a scholar working on Cancer Research, Rheumatology, Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 141 papers that have together received 3.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (32 papers), Bone Tumor Diagnosis and Treatments (19 papers), Sarcoma Diagnosis and Treatment (19 papers), Breast Lesions and Carcinomas (9 papers), HER2/EGFR in Cancer Research (5 papers), MicroRNA in disease regulation (5 papers), Soft tissue tumor case studies (5 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (711 citations), Pulmonary and Respiratory Medicine (570 citations), Pathology and Forensic Medicine (204 citations) and Rheumatology (124 citations). Shi Wei has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Gene P. Siegal, Omar Hameed, Zhiyong Ren, Tiansheng Shen, Abha Soni, Margaret S. Brandwein‐Gensler, Charity Johanna Morgan, Jie Xu, Diptiman Chanda and Kui Zhang. Their work appears in journals such as Human Pathology, Modern Pathology, Clinical Breast Cancer, Breast Cancer Research and Treatment and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.